Novo Nordisk stock rose after good news from the FDA on Wegovy—it’s popular weight-loss drug which has the same active ...

Novo Nordisk stock jumped Monday after the FDA approved the company's obesity drug, Wegovy, as a treatment for MASH.

Wall Street held near its records. The S&P 500 ended flat Monday, coming off its first loss after setting an all-time high in ...

Investors eyed risks around a high-stakes US-Ukraine meeting, kicking off a week dominated by a Federal Reserve speech that ...

Canada's main stock index opened lower on Monday as investors reined in big bets, kicking off a busy week featuring Ukraine ...

Stocks ticked lower on Monday with a number of key retailers, including Walmart, scheduled this week to issue quarterly earnings reports, and ahead of Federal Reserve Chairman Jerome Powell’s speech ...

Novo Nordisk reduces Ozempic's price to $499/month for self-paying patients, enhancing access to essential diabetes treatment ...

The minutes from the July Fed meeting will be released Wednesday, while Chair Powell will deliver a key speech at Jackson ...